Učitavanje...
Current Challenges Towards the Development of a Blood Test for Parkinson’s Disease
Parkinson’ disease (PD) is the second most prevalent neurodegenerative disease worldwide. To date, there is no disease-modifying agent, and current medical treatment only provides symptomatic benefits. Early diagnosis of PD would be useful in clinical practice to identify patients for clinical trial...
Spremljeno u:
| Izdano u: | Diagnostics (Basel) |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4665557/ https://ncbi.nlm.nih.gov/pubmed/26852683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics4040153 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|